The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 28, 2026
Snapshot (as of Sep 28, 2026): Vanguard Health Care Fund Investor Shares (VGHCX) pays a $12.98 annual dividend, yielding 6.19% at $209.49/share. Next ex-dividend date 2026-03-30. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 6.19%
Annual Dividend: $12.98 per share
Ex-Dividend Date: 2026-03-30
Dividend Frequency: annually
Sector: Financial Services
Years of Dividend History: 25
Vanguard Health Care Fund Investor Shares dividend has been paid annually for over two decades, backed by an actively managed portfolio spanning pharmaceutical developers, medical equipment manufacturers, and global healthcare research institutions. The fund currently yields 6.23%, with a trailing annual dividend rate of $12.9752 per share. The next ex-dividend date is March 30, 2026, and VGHCX pays on an annual schedule. With a beta of 0.546, the fund moves at roughly half the volatility of the broader market, which appeals to income-focused investors who want healthcare exposure without sharp price swings.
Vanguard Health Care Fund Investor Shares pays out dividends as a fund, making the traditional payout ratio not applicable (fund/ETF). Vanguard Health Care Fund Investor Shares dividend safety rests on the fund's underlying holdings across pharmaceuticals, medical equipment, and healthcare research, sectors with demand that does not disappear in economic downturns. The key pressure point is concentration: every holding sits inside the healthcare sector, so a broad regulatory shift or pricing shock affecting that industry hits the entire portfolio at once.
Vanguard Health Care Fund Investor Shares dividend history shows a CAGR of 7.2% per year from 1998 to 2024. Per-share payments grew from $3.92 in 1998 to $23.7995 in 2024 (2025 and 2026 figures are partial years and excluded from the CAGR calculation). The largest annual increase in the window was 120.5% in 2013, but the data also contains at least one year-over-year decline exceeding 5%, so growth has been uneven rather than linear.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | -8.8% | $11.59 (2022) | $8.80 (2025) |
| 5-Year | -12.5% | $17.18 (2020) | $8.80 (2025) |
| 10-Year | -6.9% | $17.97 (2015) | $8.80 (2025) |
VGHCX fits income-focused investors who want broad exposure to global healthcare, from drug developers to medical device makers, and can accept year-to-year dividend variability. The current yield is classified as high (above 4%) at 6.23%, though that sits below the 5-year average of 7.49%, meaning the fund has historically delivered even more income relative to price. Growth over the long run has been real, at 7.2% annually since 1998, but individual years swing sharply in both directions. The trade-off is straightforward: a high income stream from a diversified healthcare portfolio, offset by sector concentration and dividend amounts that do not move in a straight line.
| Payment Date | Amount per Share |
|---|---|
| 2026-03-30 | $7.6578 |
| 2025-12-19 | $5.3174 |
| 2025-03-28 | $3.4819 |
| 2024-12-20 | $17.6418 |
| 2024-03-27 | $6.1577 |
| 2023-12-27 | $8.2529 |
| 2023-03-28 | $6.7329 |
| 2022-12-28 | $3.8742 |
| 2022-03-28 | $7.7176 |
| 2021-12-29 | $15.5479 |
| Year | Total Dividends |
|---|---|
| 2026 | $7.6578 |
| 2025 | $8.7993 |
| 2024 | $23.7995 |
| 2023 | $14.9858 |
| 2022 | $11.5918 |
Project income from VGHCX with the VGHCX dividend calculator or track your full portfolio with the dividend tracker.